Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

J&J's Jane Griffiths named global head of Actelion

J&J's Jane Griffiths named global head of Actelion Griffiths is currently company group chairman at J&J’s Janssen EMEA company and will step into her new role once its purchase of Actelion is completed. ... Clozel will also take on new responsibilities, keeping control of Actelion’s early-stage

EU nod for Actelion's skin cancer drug Ledaga

EU nod for Actelion's skin cancer drug Ledaga Still need to meet CHMP post-approval requirements. Actelion has won EU approval for Ledaga, a drug to treat a rare form of lymphoma that manifests itself in the skin, but ... Actelion acquired Valchlor in 2013 when it bought Ceptaris for $250m plus

Deal Watch February 2017

Deal Watch February 2017 Actelion, Johnson &Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up.

Deal Watch January 2017

Deal Watch January 2017 Actelion, Johnson &Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up. ... The acquisition excludes the R&D portfolio which Actelion had spun out into a new standalone company.

Sosei appoints CFO

Sosei appoints CFO Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...
The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....

Infographics